| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.836 | 0.002 | 0.917 | Nav1.1 sodium channel blocker | 0.917 0.001 CID_6540813 0.773 0.002 CID_40572060 | CID_6540813 | |
| 0.81 | 0.004 | 0.817 | Anticonvulsant | 0.817 0.004 CID_6540813 0.645 0.005 CID_40572060 | CID_6540813 | |
| 0.566 | 0.002 | 0.566 | Liver X receptor agonist | 0.389 0.003 CID_6540813 0.47 0.003 CID_40572060 | ||
| 0.574 | 0.059 | 0.574 | Beta lactamase inhibitor | 0.42 0.094 CID_6540813 0.421 0.094 CID_40572060 | ||
| 0.379 | 0.008 | 0.577 | Tumour necrosis factor antagonist | 0.577 0.003 CID_6540813 0.37 0.009 CID_40572060 | CID_6540813 | |
| 0.398 | 0.062 | 0.43 | GABA C receptor rho-3 antagonist | 0.371 0.075 CID_6540813 0.43 0.049 CID_40572060 | CID_40572060 | |
| 0.34 | 0.039 | 0.52 | Superoxide dismutase inhibitor | 0.52 0.011 CID_6540813 0.418 0.024 CID_40572060 | CID_6540813 | |
| 0.353 | 0.059 | 0.353 | Immunomodulator | 0.338 0.064 CID_6540813 0.301 0.082 CID_40572060 | ||
| 0.297 | 0.02 | 0.297 | Neuropeptide Y2 antagonist | 0.262 0.045 CID_6540813 0.295 0.021 CID_40572060 | ||
| 0.35 | 0.077 | 0.405 | Thioredoxin glutathione reductase inhibitor | 0.405 0.055 CID_6540813 0.324 0.088 CID_40572060 | CID_6540813 | |
| 0.308 | 0.039 | 0.318 | Cyclic AMP phosphodiesterase inhibitor | 0.237 0.07 CID_6540813 0.318 0.035 CID_40572060 | CID_40572060 | |
| 0.295 | 0.034 | 0.32 | Anesthetic general | 0.289 0.036 CID_6540813 0.32 0.029 CID_40572060 | CID_40572060 | |
| 0.357 | 0.097 | 0.425 | Histamine release inhibitor | 0.213 0.187 CID_6540813 0.425 0.062 CID_40572060 | CID_40572060 | |
| 0.29 | 0.034 | 0.321 | RNA-directed DNA polymerase inhibitor | 0.32 0.028 CID_6540813 0.321 0.028 CID_40572060 | CID_40572060 | |
| 0.297 | 0.067 | 0.546 | Aldehyde oxidase inhibitor | 0.472 0.037 CID_6540813 0.546 0.026 CID_40572060 | CID_40572060 | |
| 0.272 | 0.049 | 0.337 | Tyrosine 3 hydroxylase inhibitor | 0.269 0.052 CID_6540813 0.337 0.019 CID_40572060 | CID_40572060 | |
| 0.253 | 0.032 | 0.253 | Lipocortins synthesis antagonist | 0.161 0.091 CID_6540813 0.24 0.037 CID_40572060 | ||
| 0.243 | 0.024 | 0.412 | Interleukin 6 antagonist | 0.412 0.007 CID_6540813 0.245 0.024 CID_40572060 | CID_6540813 | |
| 0.244 | 0.028 | 0.244 | Histone acetyltransferase inhibitor | 0.162 0.123 CID_6540813 0.236 0.033 CID_40572060 | ||
| 0.228 | 0.021 | 0.245 | Cell wall synthesis inhibitor | 0.131 0.085 CID_6540813 0.245 0.017 CID_40572060 | CID_40572060 | |
| 0.204 | 0.013 | 0.27 | DNA directed RNA polymerase inhibitor | 0.27 0.008 CID_6540813 0.167 0.019 CID_40572060 | CID_6540813 | |
| 0.27 | 0.08 | 0.273 | 5 Hydroxytryptamine release stimulant | 0.238 0.095 CID_6540813 0.273 0.079 CID_40572060 | CID_40572060 | |
| 0.202 | 0.018 | 0.333 | Nav1.6 sodium channel blocker | 0.333 0.005 CID_6540813 0.169 0.035 CID_40572060 | CID_6540813 | |
| 0.342 | 0.16 | 0.389 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.389 0.11 CID_6540813 | CID_6540813 | |
| 0.241 | 0.062 | 0.241 | Psychostimulant | 0.138 0.127 CID_6540813 0.221 0.07 CID_40572060 | ||
| 0.2 | 0.022 | 0.2 | Ferrochelatase inhibitor | 0.199 0.023 CID_6540813 0.113 0.059 CID_40572060 | ||
| 0.254 | 0.077 | 0.254 | 5 Hydroxytryptamine uptake stimulant | 0.231 0.103 CID_6540813 0.247 0.084 CID_40572060 | ||
| 0.196 | 0.026 | 0.303 | Nav1.3 sodium channel blocker | 0.303 0.009 CID_6540813 0.142 0.053 CID_40572060 | CID_6540813 | |
| 0.2 | 0.034 | 0.375 | Nav1.2 sodium channel blocker | 0.375 0.008 CID_6540813 0.152 0.056 CID_40572060 | CID_6540813 | |
| 0.163 | 0.005 | 0.163 | Kinesin antagonist | 0.082 0.01 CID_6540813 0.143 0.005 CID_40572060 | ||
| 0.163 | 0.005 | 0.163 | Kinesin-like protein 1 inhibitor | 0.082 0.01 CID_6540813 0.143 0.005 CID_40572060 | ||
| 0.19 | 0.035 | 0.193 | GABA C receptor rho-2 antagonist | 0.193 0.033 CID_6540813 0.182 0.041 CID_40572060 | CID_6540813 | |
| 0.129 | 0.007 | 0.129 | Polo-like kinase-2 inhibitor | 0.084 0.04 CID_6540813 0.113 0.015 CID_40572060 | ||
| 0.124 | 0.004 | 0.128 | Liver X receptor beta agonist | 0.05 0.01 CID_6540813 0.128 0.004 CID_40572060 | CID_40572060 | |
| 0.223 | 0.105 | 0.223 | 5 Hydroxytryptamine 1E antagonist | 0.212 0.118 CID_40572060 | ||
| 0.247 | 0.129 | 0.254 | Vasodilator, peripheral | 0.254 0.124 CID_40572060 | CID_40572060 | |
| 0.117 | 0.005 | 0.154 | Liver X receptor alpha agonist | 0.058 0.014 CID_6540813 0.154 0.004 CID_40572060 | CID_40572060 | |
| 0.148 | 0.038 | 0.148 | Alpha adrenoreceptor antagonist | 0.109 0.052 CID_40572060 | ||
| 0.119 | 0.01 | 0.119 | Secretase beta inhibitor | 0.102 0.017 CID_6540813 0.095 0.021 CID_40572060 | ||
| 0.235 | 0.136 | 0.297 | Cholesterol antagonist | 0.297 0.093 CID_40572060 | CID_40572060 | |
| 0.148 | 0.051 | 0.159 | Heat shock protein 70 antagonist | 0.159 0.029 CID_40572060 | CID_40572060 | |
| 0.217 | 0.123 | 0.217 | Gastrin inhibitor | 0.19 0.164 CID_6540813 | ||
| 0.136 | 0.044 | 0.136 | 5 Hydroxytryptamine 3A agonist | 0.122 0.054 CID_6540813 0.116 0.06 CID_40572060 | ||
| 0.123 | 0.033 | 0.413 | Alcohol dehydrogenase inhibitor | 0.413 0.004 CID_6540813 0.189 0.014 CID_40572060 | CID_6540813 | |
| 0.1 | 0.01 | 0.1 | Phosphodiesterase 1A inhibitor | 0.073 0.022 CID_6540813 0.07 0.025 CID_40572060 | ||
| 0.114 | 0.024 | 0.126 | HIV-1 reverse transcriptase inhibitor | 0.126 0.02 CID_6540813 0.099 0.031 CID_40572060 | CID_6540813 | |
| 0.124 | 0.035 | 0.124 | Alpha 1 adrenoreceptor antagonist | 0.084 0.051 CID_40572060 | ||
| 0.203 | 0.119 | 0.242 | DNA synthesis inhibitor | 0.242 0.072 CID_6540813 0.223 0.091 CID_40572060 | CID_6540813 | |
| 0.119 | 0.037 | 0.119 | Electrolyte absorption antagonist | 0.098 0.061 CID_6540813 0.094 0.068 CID_40572060 | ||
| 0.226 | 0.148 | 0.247 | Antithrombotic | 0.193 0.186 CID_6540813 0.247 0.128 CID_40572060 | CID_40572060 | |
| 0.082 | 0.005 | 0.083 | Pregnane X receptor antagonist | 0.083 0.005 CID_6540813 0.082 0.006 CID_40572060 | CID_6540813 | |
| 0.109 | 0.033 | 0.109 | Alpha 1a adrenoreceptor antagonist | 0.073 0.049 CID_40572060 | ||
| 0.126 | 0.054 | 0.229 | Cystathionine beta-synthase inhibitor | 0.229 0.019 CID_40572060 | CID_40572060 | |
| 0.187 | 0.118 | 0.261 | Peptidyltransferase inhibitor | 0.261 0.043 CID_6540813 0.224 0.073 CID_40572060 | CID_6540813 | |
| 0.226 | 0.157 | 0.236 | Vasodilator, coronary | 0.236 0.148 CID_40572060 | CID_40572060 | |
| 0.084 | 0.016 | 0.118 | MDM2 inhibitor | 0.118 0.004 CID_6540813 0.071 0.037 CID_40572060 | CID_6540813 | |
| 0.108 | 0.039 | 0.113 | Phosphodiesterase 6D inhibitor | 0.113 0.033 CID_40572060 | CID_40572060 | |
| 0.106 | 0.038 | 0.106 | Phosphodiesterase I inhibitor | 0.087 0.064 CID_6540813 0.097 0.048 CID_40572060 | ||
| 0.087 | 0.02 | 0.087 | Glutamate (mGluR7) antagonist | 0.067 0.048 CID_6540813 0.08 0.028 CID_40572060 | ||
| 0.169 | 0.105 | 0.169 | MAP kinase kinase 2 inhibitor | 0.159 0.113 CID_40572060 | ||
| 0.075 | 0.012 | 0.099 | Nicotinic acid receptor 1 agonist | 0.099 0.008 CID_6540813 0.057 0.017 CID_40572060 | CID_6540813 | |
| 0.279 | 0.218 | 0.338 | Caspase 9 stimulant | 0.293 0.201 CID_6540813 0.338 0.155 CID_40572060 | CID_40572060 | |
| 0.082 | 0.023 | 0.1 | Androgen agonist | 0.097 0.016 CID_6540813 0.1 0.014 CID_40572060 | CID_40572060 | |
| 0.087 | 0.029 | 0.087 | 5 Hydroxytryptamine 7 antagonist | 0.053 0.052 CID_40572060 | ||
| 0.114 | 0.059 | 0.114 | Acetylcholine release stimulant | |||
| 0.062 | 0.007 | 0.062 | Phosphodiesterase 6C inhibitor | 0.057 0.011 CID_40572060 | ||
| 0.105 | 0.055 | 0.121 | GABA C receptor rho-1 antagonist | 0.121 0.039 CID_6540813 0.095 0.07 CID_40572060 | CID_6540813 | |
| 0.165 | 0.117 | 0.206 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.206 0.067 CID_40572060 | CID_40572060 | |
| 0.081 | 0.033 | 0.081 | Acetylcholine M5 receptor agonist | 0.069 0.044 CID_6540813 | ||
| 0.136 | 0.089 | 0.137 | Ca2+-transporting ATPase inhibitor | 0.137 0.085 CID_6540813 0.135 0.092 CID_40572060 | CID_6540813 | |
| 0.073 | 0.028 | 0.073 | Phosphodiesterase 1B inhibitor | 0.056 0.048 CID_6540813 0.062 0.039 CID_40572060 | ||
| 0.099 | 0.056 | 0.099 | Antiadrenergic | 0.09 0.063 CID_40572060 | ||
| 0.099 | 0.057 | 0.127 | Prolactin inhibitor | 0.127 0.034 CID_40572060 | CID_40572060 | |
| 0.07 | 0.029 | 0.07 | Phosphodiesterase 1C inhibitor | 0.065 0.036 CID_6540813 0.063 0.04 CID_40572060 | ||
| 0.087 | 0.047 | 0.095 | Glycine receptor antagonist | 0.095 0.037 CID_6540813 | CID_6540813 | |
| 0.096 | 0.056 | 0.096 | Adrenaline antagonist | 0.087 0.062 CID_40572060 | ||
| 0.046 | 0.008 | 0.046 | Phosphodiesterase 6B inhibitor | 0.038 0.013 CID_40572060 | ||
| 0.099 | 0.062 | 0.178 | UDP-glucose 4-epimerase inhibitor | 0.178 0.022 CID_6540813 0.108 0.053 CID_40572060 | CID_6540813 | |
| 0.175 | 0.141 | 0.197 | Spasmolytic | 0.197 0.122 CID_40572060 | CID_40572060 | |
| 0.039 | 0.005 | 0.039 | DNA polymerase III inhibitor | 0.035 0.008 CID_6540813 0.034 0.009 CID_40572060 | ||
| 0.038 | 0.005 | 0.038 | Acid ceramidase inhibitor | 0.03 0.01 CID_6540813 0.025 0.02 CID_40572060 | ||
| 0.046 | 0.018 | 0.286 | Aggrecanase 1 inhibitor | 0.286 0.003 CID_6540813 0.043 0.02 CID_40572060 | CID_6540813 | |
| 0.048 | 0.02 | 0.058 | Thymidine kinase inhibitor | 0.058 0.014 CID_6540813 0.039 0.033 CID_40572060 | CID_6540813 | |
| 0.044 | 0.017 | 0.045 | Potassium channel Kv1.1 blocker | 0.045 0.017 CID_6540813 | CID_6540813 | |
| 0.086 | 0.062 | 0.086 | Bromodomain-containing protein 2 inhibitor | |||
| 0.03 | 0.007 | 0.03 | Phosphodiesterase 6H inhibitor | 0.027 0.011 CID_40572060 | ||
| 0.03 | 0.007 | 0.03 | Phosphodiesterase 6G inhibitor | 0.027 0.011 CID_40572060 | ||
| 0.046 | 0.024 | 0.046 | Angiotensin AT1 receptor antagonist | 0.039 0.036 CID_6540813 | ||
| 0.071 | 0.05 | 0.089 | Phospholipase D inhibitor | 0.089 0.023 CID_6540813 | CID_6540813 | |
| 0.225 | 0.205 | 0.225 | Transcription factor inhibitor | |||
| 0.039 | 0.022 | 0.083 | Nicotinic acid receptor agonist | 0.083 0.006 CID_6540813 0.058 0.012 CID_40572060 | CID_6540813 | |
| 0.027 | 0.01 | 0.027 | Phosphodiesterase 6A inhibitor | 0.023 0.016 CID_40572060 | ||
| 0.058 | 0.041 | 0.058 | Calcium channel T-type blocker | |||
| 0.07 | 0.053 | 0.07 | Alpha 1b adrenoreceptor antagonist | |||
| 0.036 | 0.02 | 0.036 | Purinergic P2Y2 antagonist | 0.033 0.024 CID_40572060 | ||
| 0.111 | 0.096 | 0.14 | Sodium channel (voltage-gated) blocker | 0.14 0.062 CID_6540813 | CID_6540813 | |
| 0.11 | 0.095 | 0.11 | DNA repair enzyme inhibitor | 0.11 0.097 CID_6540813 0.108 0.1 CID_40572060 | ||
| 0.169 | 0.155 | 0.215 | Nitric-oxide synthase stimulant | 0.215 0.066 CID_6540813 0.188 0.111 CID_40572060 | CID_6540813 | |
| 0.031 | 0.017 | 0.064 | Uridine phosphorylase inhibitor | 0.064 0.005 CID_6540813 0.026 0.021 CID_40572060 | CID_6540813 | |
| 0.027 | 0.016 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.032 0.009 CID_6540813 | CID_6540813 | |
| 0.041 | 0.03 | 0.051 | Kainate receptor agonist | 0.051 0.013 CID_6540813 0.039 0.035 CID_40572060 | CID_6540813 | |
| 0.015 | 0.005 | 0.016 | DNA polymerase III polC-type inhibitor | 0.016 0.005 CID_6540813 0.013 0.009 CID_40572060 | CID_6540813 | |
| 0.026 | 0.019 | 0.034 | Thymidine phosphorylase inhibitor | 0.034 0.009 CID_6540813 | CID_6540813 | |
| 0.025 | 0.018 | 0.048 | Calcitonin gene-related peptide antagonist | 0.048 0.011 CID_6540813 | CID_6540813 | |
| 0.046 | 0.039 | 0.046 | Adenosine A2b receptor antagonist | |||
| 0.056 | 0.049 | 0.056 | TRPA1 antagonist | |||
| 0.069 | 0.065 | 0.069 | Phosphodiesterase VI inhibitor | |||
| 0.051 | 0.047 | 0.051 | Adenosine A1 receptor antagonist | |||
| 0.032 | 0.028 | 0.032 | Angiotensin II receptor antagonist | |||
| 0.068 | 0.065 | 0.068 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.122 | 0.12 | 0.122 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.036 | 0.034 | 0.052 | Membrane dipeptidase inhibitor | 0.052 0.014 CID_6540813 | CID_6540813 | |
| 0.015 | 0.014 | 0.016 | Calcitonin gene-related peptide 1 receptor antagonist | 0.016 0.014 CID_6540813 | CID_6540813 | |
| 0.083 | 0.082 | 0.15 | Creatine kinase inhibitor | 0.089 0.073 CID_6540813 0.15 0.024 CID_40572060 | CID_40572060 | |
| 0.082 | 0.083 | 0.109 | Bronchodilator | 0.109 0.053 CID_40572060 | CID_40572060 | |
| 0.092 | 0.092 | 0.117 | GABA C receptor antagonist | 0.117 0.056 CID_6540813 | CID_6540813 | |
| 0.1 | 0.101 | 0.154 | Alpha-N-acetylglucosaminidase inhibitor | 0.154 0.053 CID_6540813 | CID_6540813 | |
| 0.136 | 0.137 | 0.149 | Antimitotic | 0.149 0.122 CID_40572060 | CID_40572060 | |
| 0.019 | 0.022 | 0.028 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.028 0.005 CID_6540813 | CID_6540813 | |
| 0.005 | 0.011 | 0.015 | DNA topoisomerase III inhibitor | 0.015 0.003 CID_6540813 | CID_6540813 | |
| 0.048 | 0.056 | 0.101 | Biliverdin reductase inhibitor | 0.101 0.018 CID_6540813 | CID_6540813 | |
| 0.048 | 0.057 | 0.06 | Fatty acid synthase inhibitor | 0.06 0.035 CID_40572060 | CID_40572060 | |
| 0.021 | 0.032 | 0.051 | Nicotinic acid receptor 2 antagonist | 0.051 0.004 CID_6540813 | CID_6540813 | |
| 0.16 | 0.172 | 0.174 | 5 Hydroxytryptamine 3E antagonist | 0.174 0.124 CID_6540813 | CID_6540813 | |
| 0.014 | 0.027 | 0.096 | Aggrecanase 2 inhibitor | 0.096 0.004 CID_6540813 | CID_6540813 | |
| 0.075 | 0.088 | 0.096 | Estrogen-related receptor beta agonist | 0.096 0.03 CID_40572060 | CID_40572060 | |
| 0.115 | 0.13 | 0.244 | Growth hormone agonist | 0.244 0.045 CID_6540813 0.14 0.095 CID_40572060 | CID_6540813 | |
| 0.075 | 0.091 | 0.153 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.153 0.026 CID_6540813 | CID_6540813 | |
| 0.044 | 0.066 | 0.065 | Carbamoyl phosphate synthetase inhibitor | 0.065 0.039 CID_6540813 | CID_6540813 | |
| 0.078 | 0.103 | 0.109 | Anabolic | 0.109 0.051 CID_6540813 0.098 0.066 CID_40572060 | CID_6540813 | |
| 0.026 | 0.054 | 0.043 | ADAM10 endopeptidase inhibitor | 0.043 0.013 CID_6540813 | CID_6540813 | |
| 0.046 | 0.079 | 0.069 | Lipase inhibitor | 0.069 0.056 CID_40572060 | CID_40572060 | |
| 0.017 | 0.05 | 0.023 | Glutamate (mGluR1) agonist | 0.023 0.021 CID_6540813 | CID_6540813 | |
| 0.073 | 0.108 | 0.123 | GABA C receptor agonist | 0.123 0.047 CID_6540813 | CID_6540813 | |
| 0.08 | 0.115 | 0.099 | Mucolytic | 0.099 0.079 CID_40572060 | CID_40572060 | |
| 0.039 | 0.076 | 0.066 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.066 0.029 CID_6540813 | CID_6540813 | |
| 0.071 | 0.109 | 0.089 | Phosphodiesterase 7B inhibitor | 0.089 0.071 CID_6540813 | CID_6540813 | |
| 0.068 | 0.108 | 0.103 | NADH dehydrogenase inhibitor | 0.103 0.041 CID_6540813 | CID_6540813 | |
| 0.038 | 0.078 | 0.056 | NMDA receptor glycine site agonist | 0.056 0.05 CID_6540813 | CID_6540813 | |
| 0.089 | 0.131 | 0.115 | Sodium channel blocker | 0.115 0.09 CID_6540813 | CID_6540813 | |
| 0.035 | 0.077 | 0.073 | Argininosuccinate synthase inhibitor | 0.073 0.028 CID_6540813 | CID_6540813 | |
| 0.07 | 0.114 | 0.092 | Expectorant | 0.092 0.078 CID_40572060 | CID_40572060 | |
| 0.182 | 0.227 | 0.218 | Toll-Like receptor 7 agonist | 0.218 0.18 CID_6540813 | CID_6540813 | |
| 0.041 | 0.088 | 0.078 | Dihydroorotate oxidase inhibitor | 0.078 0.012 CID_6540813 | CID_6540813 | |
| 0.178 | 0.231 | 0.214 | Toll-Like receptor agonist | 0.214 0.185 CID_6540813 | CID_6540813 | |
| 0.052 | 0.105 | 0.068 | Glutamate (mGluR6) antagonist | 0.068 0.045 CID_6540813 | CID_6540813 | |
| 0.177 | 0.232 | 0.232 | Interleukin 2 agonist | 0.232 0.14 CID_40572060 | CID_40572060 | |
| 0.058 | 0.113 | 0.08 | Antineoplastic alkaloid | 0.08 0.066 CID_40572060 | CID_40572060 | |
| 0.076 | 0.132 | 0.094 | Adenylate kinase inhibitor | 0.094 0.079 CID_6540813 | CID_6540813 | |
| 0.023 | 0.081 | 0.032 | Protein kinase (CK2) beta inhibitor | 0.032 0.027 CID_6540813 | CID_6540813 | |
| 0.037 | 0.095 | 0.084 | Collagenase 3 inhibitor | 0.084 0.022 CID_6540813 | CID_6540813 | |
| 0.016 | 0.075 | 0.03 | Fumarate hydratase inhibitor | 0.03 0.029 CID_6540813 | CID_6540813 | |
| 0.037 | 0.096 | 0.077 | Phosphofructokinase-1 inhibitor | 0.077 0.043 CID_6540813 | CID_6540813 | |
| 0.051 | 0.116 | 0.091 | Metalloproteinase-9 inhibitor | 0.091 0.037 CID_6540813 | CID_6540813 | |
| 0.104 | 0.172 | 0.132 | DNA methyltransferase I inhibitor | 0.132 0.126 CID_40572060 | CID_40572060 | |
| 0.033 | 0.106 | 0.061 | Phosphodiesterase III inhibitor | 0.061 0.051 CID_6540813 | CID_6540813 | |
| 0.019 | 0.092 | 0.171 | Macrophage elastase inhibitor | 0.171 0.005 CID_6540813 | CID_6540813 | |
| 0.028 | 0.104 | 0.049 | Alcohol oxidase inhibitor | 0.049 0.047 CID_6540813 | CID_6540813 | |
| 0.046 | 0.127 | 0.1 | Metalloproteinase-2 inhibitor | 0.1 0.038 CID_6540813 | CID_6540813 | |
| 0.036 | 0.12 | 0.064 | Histidine decarboxylase inhibitor | 0.064 0.058 CID_40572060 | CID_40572060 | |
| 0.063 | 0.147 | 0.078 | D-Ala-D-Ala ligase inhibitor | 0.078 0.074 CID_40572060 | CID_40572060 | |
| 0.047 | 0.135 | 0.074 | NMDA receptor antagonist | 0.074 0.073 CID_40572060 | CID_40572060 | |
| 0.194 | 0.284 | 0.332 | Calcium channel L-type activator | 0.244 0.212 CID_6540813 0.332 0.131 CID_40572060 | CID_40572060 | |
| 0.113 | 0.206 | 0.162 | Neurotrophic factor enhancer | 0.162 0.121 CID_40572060 | CID_40572060 | |
| 0.013 | 0.112 | 0.042 | Nicotinic acid receptor 2 agonist | 0.042 0.019 CID_6540813 | CID_6540813 | |
| 0.007 | 0.106 | 0.019 | Thyroid hormone alpha agonist | 0.019 0.008 CID_6540813 | CID_6540813 | |
| 0.027 | 0.126 | 0.06 | Matrix metalloproteinase (membrane-type) inhibitor | 0.06 0.033 CID_6540813 | CID_6540813 | |
| 0.03 | 0.131 | 0.075 | Matrix metalloproteinase inhibitor | 0.075 0.04 CID_6540813 | CID_6540813 | |
| 0.051 | 0.154 | 0.106 | HIV-1 integrase (Overall Integration) inhibitor | 0.106 0.049 CID_6540813 | CID_6540813 | |
| 0.106 | 0.222 | 0.145 | Succinate dehydrogenase inhibitor | 0.145 0.123 CID_6540813 | CID_6540813 | |
| 0.073 | 0.193 | 0.14 | Peroxidase inhibitor | 0.119 0.1 CID_6540813 0.14 0.084 CID_40572060 | CID_40572060 | |
| 0.144 | 0.266 | 0.188 | Insulysin inhibitor | 0.188 0.176 CID_6540813 | CID_6540813 | |
| 0.142 | 0.273 | 0.24 | Alpha-glucosidase inhibitor | 0.24 0.194 CID_40572060 | CID_40572060 | |
| 0.064 | 0.196 | 0.098 | DOPA decarboxylase inhibitor | 0.098 0.08 CID_40572060 | CID_40572060 | |
| 0.016 | 0.156 | 0.106 | Aldose reductase inhibitor | 0.106 0.017 CID_6540813 | CID_6540813 | |
| 0.107 | 0.252 | 0.143 | Neurotensin receptor agonist | 0.143 0.119 CID_6540813 | CID_6540813 | |
| 0.041 | 0.198 | 0.078 | Keratolytic | 0.078 0.051 CID_6540813 | CID_6540813 | |
| 0.178 | 0.348 | 0.266 | 5 Hydroxytryptamine release inhibitor | 0.266 0.207 CID_6540813 | CID_6540813 | |
| 0.05 | 0.224 | 0.088 | Interleukin 5 antagonist | 0.088 0.057 CID_6540813 | CID_6540813 | |
| 0.112 | 0.353 | 0.245 | Sodium/bile acid cotransporter inhibitor | 0.245 0.133 CID_40572060 | CID_40572060 | |
| 0.033 | 0.355 | 0.108 | Lipid peroxidase inhibitor | 0.108 0.107 CID_40572060 | CID_40572060 | |
| 0.034 | 0.409 | 0.126 | Estrogen antagonist | 0.126 0.045 CID_40572060 | CID_40572060 | |
| 0.022 | 0.444 | 0.112 | Estrogen receptor beta antagonist | 0.112 0.043 CID_40572060 | CID_40572060 | |
| 0.039 | 0.483 | 0.298 | Tumour necrosis factor alpha release inhibitor | 0.298 0.054 CID_6540813 | CID_6540813 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |